Estelle Black 11/22/21 Estelle Black 11/22/21

MedWorld Advisors @ Medica 2021

MedWorld Advisors at Medica 2021.

MedWorld Advisors 11/10/21 MedWorld Advisors 11/10/21

What’s Next for Medtech’s Top Companies 2022?

It’s an ideal time to reflect upon the 2021 performance of MedTech’s largest OEMs and portend their growth prospects for the coming year.

Estelle Black 11/4/21 Estelle Black 11/4/21

Revelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company’s Diagnostic Tool, REVID

Revelation Biosciences Inc. engages partnering advisor, MedWorld Advisors, to optimize value of the company’s diagnostic tool, REVID

Dave & Flo 10/25/21 Dave & Flo 10/25/21

Orthopedic Industry Insights and Reflections

We’ve attended the AAOS Annual Meeting many times over the years to gain insights into this $50 billion market (estimated). The meeting has provided valuable data about orthopedic industry trends and its impacts on other healthcare market segments. Clearly, orthopedics is a sector that cannot and should not be ignored.

Estelle Black 10/21/21 Estelle Black 10/21/21

Are We in an M&A Bubble?

Are we in an M&A bubble? And if we are, how will this affect transaction multiples moving into 2022 and beyond? From our recent webinar series MedTech M&A: A Financial Buyer's Perspective, Managing Director - Middle Markets Daniel Sheppard asks this very question to our panel of industry professionals.

Dave Sheppard 10/20/21 Dave Sheppard 10/20/21

MedTech Co-opetition is Maturing in a Positive Way

In 2021, the need for collaboration on a B2B level has never been more apparent, which is great for our industry. The more that our medtech industry opens up and works together (even while competing) the more growth it creates for us all. It also creates possibilities for more efficiency in our healthcare system.

Estelle Black 10/13/21 Estelle Black 10/13/21

MedWorld Advisors Once Again Listed to Axial’s Top 20 Lower Middle Market Investment Banks

MedWorld Advisors once again named to Axial’s Top 20 Lower Middle Market Investment Banks for Q3 2021.

Estelle Black 10/12/21 Estelle Black 10/12/21

Today’s Medical Development: Anatomy of an M&A Deal - From Analysis to Valuation

Hear MedWorld Advisors CEO Florence Joffroy-Black and Managing Director Dave Sheppard as they answer the question "What is the likely valuation of a business and what does it take to sell it?". From the start all the way to the transaction, listen as they walk you through the M&A process with a healthcare industry focus.

Estelle Black 9/29/21 Estelle Black 9/29/21

MedTech M&A Series: A Financial Buyer’s Perspective

Listen to Daniel Sheppard’s conversation with Eric Tansky, General Partner at Accelmed, Mike Magliochetti, PhD, Operating Partner at Riverside Partners, and Steve Sandbo, Principal at Vance Street Capital. In this installment, Dan covers everything from deal origination to transaction structure, as well as the MedTech/Healhcare M&A space as a whole from a private equity perspective.

MedWorld Advisors 9/15/21 MedWorld Advisors 9/15/21

MedWorld Advisors Plays a Key Role in Fighting Corona Virus

MedWorld Advisors plays a key role in fighting Corona Virus. In 2020 We were pleased and honored to announce the Strategic Alliance between Airon USA and GE as part of the current fight against the Corona Virus.

Estelle Black 9/13/21 Estelle Black 9/13/21

MedWorld Advisors Named #6 on Axial’s Top 20 Lower Middle Market Investment Banks

MedWorld Advisors is pleased to announce that we have been named #6 on Axial’s Q2 2021 Top 20 Lower Middle Market Investment Banks!

Estelle Black 9/9/21 Estelle Black 9/9/21

MedWorld Advisors @ MPO Summit 2021

MedWorld Advisors recaps the MPO (Medical Product Outsourcing) Summit 2021 in Salt Lake City, UT.

Estelle Black 9/8/21 Estelle Black 9/8/21

MedWorld Advisors @ AAOS 2021

MedWorld Advisors recaps the AAOS (American Academy of Orthopedic Surgeons) Conference in San Diego, CA.

MedWorld Advisors 8/24/21 MedWorld Advisors 8/24/21

MedTech M&A Series: A Strategic Buyer’s Perspective

Listen to Co-Founder and Managing Director Dave Sheppard’s conversation with Charlie Attlan of Boston Scientific, Eric Knudsen of ZOLL Medical and Tom Gales of Draeger. Part of our MedTech M&A Series, the panel for A Strategic Buyer’s Perspective discussed everything from how M&A strategy fits into their respective companies to deal origination and structure.

MedWorld Advisors 8/19/21 MedWorld Advisors 8/19/21

MedWorld Advisors @ MD&M West 2021

MedWorld Advisors recaps MD&M West (Medical Design and Manufacturing) 2021.

MedWorld Advisors 8/18/21 MedWorld Advisors 8/18/21

MedWorld Advisors @ HIMSS 2021

MedWorld Advisors recaps HIMSS (The Healthcare Information and Management Systems Society) 2021.

MedWorld Advisors 8/2/21 MedWorld Advisors 8/2/21

How an Idea Reaches Strategic Buyers

At a recent panel hosted by MedWorld’s Dave Sheppard, three MedTech Executives provided insight into how business ideas are relayed up the chain of command. To ensure that deals are made efficiently, it’s important that buying and selling companies understand each other’s corporate strategies during the earliest stages of business development.

MedWorld Advisors 6/3/21 MedWorld Advisors 6/3/21

Getting a Medical Device Strategic Buyer’s Attention

Managing Director Daniel Sheppard joined MDG Premium with his wife Shannon for a Q&A session covering things from the role MedWorld Advisors plays in the development of early-stage companies to when along the process it’s advantageous to bring an advisory team on board. A group of medical device entrepreneurs then joined to discuss their own journeys and pose questions.

MedWorld Advisors 6/3/21 MedWorld Advisors 6/3/21

10x Medical Device Conference: Interview with Daniel Sheppard

At the 10x Medical Device Conference, where the medical device ecosystem comes together to learn from and network with each other, host Joe Hage interviewed Managing Director Daniel Sheppard. Their conversation included what an ideal company looks like, how to prepare a company for a deal, developing commercialization strategies and more.

MedWorld Advisors 5/31/21 MedWorld Advisors 5/31/21

Valuing a MedTech Business

Some of the most common questions we’re asked relate to business valuation. While a one-size-fits-all answer doesn’t exist, there are some general guidelines that can be referenced. CEO Florence Joffroy-Black and Managing Director Dave Sheppard discussed key factors that affect the value of your business in a recent article for Today’s Medical Developments Magazine.

Contact us.